返回 Agendas
Session 2A: CMC Track: Emerging Trends
Session Chair(s)
Stephen R Sofen, PHD
CMC Team Director
Biogen Idec, United States
This session will focus on the emerging field of mRNA therapeutics and feature two presentations followed by a panel discussion. The presenters will discuss CMC challenges associated with the manufacture of long coding RNAs. Potential topics for discussion include:
• Purity requirements for long RNA
• RNA stability
Speaker(s)
cGMP Manufacturing of mRNA Products: Considerations and Challenges
Gary Lee, PHD
Sangamo BioSciences, Inc., United States
Research Scientist
Manufacturing of Long, Coding RNAs
Andreas Kuhn, PHD
Biontech SE, Germany
Senior Vice President RNA Biochemistry & CMC Development
Q&A Panel Discussion (Joining the Speakers):
René Thürmer, PHD
Federal Institute for Drugs and Medical Devices, Germany
Quality Assessor
James D. Thompson, PHD
Moderna Therapeutics , United States
CMC Therapeutic Area Lead